Lastly, the choice of study population may also be of significant influence, as e.g. in early breast cancer ESR1 amplification was detected at a lower frequency (14% of ER positive cases in BIG 1-98 trial) [39] compared to advanced stage breast cancer (23% revealed by the same FISH technique) [26]. This evidence concerns the gene ESR1 and breast carcinoma.